Hospital drug committees have been established to ensure rational drug use.
However, with regard to their structure and duties remarkable differences between European countries may exist, reflecting the differences in drug legislation and market.
Our aim was to obtain information about the structure, present activities and decision-making processes of hospital drug committees in Germany and especially the role of clinical pharmacologists in these committees.
In 1995, a questionnaire with 36 items was designed and sent to all 450 hospitals in Germany with more than 400 beds.
One hundred forty three returned questionnaires were evaluated.
According to hospital size, the median value for the annual drug budget (including the cost of blood and blood-derived products) in 1993 ranged between DM 2.4 million for hospitals with less than 500 beds and DM 30.0 million for university hospitals with more than 1 000 beds.
In 53.2% of drug committees, a pharmacist holds the position of chairman, followed by medical specialists (32%) ; (clinical) pharmacologists hold this position in only 7.7% of the general hospitals, but in almost 50% of the university hospitals.
In most cases, all clinical specialities are represented in the drug committee, the number of members ranging between 5 and 40 (median 12). (...)
Mots-clés Pascal : Gestion hospitalière, Planification, Hôpital, Médicament, Allemagne, Europe, Prescription médicale, Information thérapeutique, Pharmacologie, Rationalisation, Contrôle coût, Recommandation, Pharmacie hospitalière
Mots-clés Pascal anglais : Hospital management, Planning, Hospital, Drug, Germany, Europe, Medical prescription, Therapeutic information, Pharmacology, Rationalization, Cost control, Recommendation, Hospital pharmacy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0482606
Code Inist : 002B30A04D. Création : 03/02/1998.